Other
Common stock, capital shares reserved for future issuance
Guardant Health Common stock, capital shares reserved for future issuance increased by 13.9% to $32.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $31.31M to $32.08M. Over 5 years (FY 2020 to FY 2025), Common stock, capital shares reserved for future issuance shows an upward trend with a 19.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2017
Last reportedQ1 2026May 7, 2026
Metric ID:
other_common_stock_capital_shares_reserved_for_future_issuanceHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.94M | $13.57M | $13.42M | $16.97M | $16.68M | $16.46M | $16.25M | $20.88M | $20.3M | $25.11M | $24.72M | $29.35M | $28.17M | $27.98M | $27.15M | $31.31M | $30.48M | $29.96M | $28.16M | $32.08M |
| QoQ Change | — | -2.7% | -1.1% | +26.5% | -1.7% | -1.4% | -1.3% | +28.5% | -2.8% | +23.7% | -1.6% | +18.8% | -4.0% | -0.7% | -3.0% | +15.3% | -2.7% | -1.7% | -6.0% | +13.9% |
| YoY Change | — | — | — | — | +19.7% | +21.3% | +21.1% | +23.0% | +21.7% | +52.6% | +52.1% | +40.6% | +38.8% | +11.4% | +9.8% | +6.7% | +8.2% | +7.0% | +3.7% | +2.4% |
Range$13.42M – $32.08M
CAGR+19.2%
Avg YoY Growth+21.3%
Median YoY Growth+20.4%
Common stock, capital shares reserved for future issuance at Other Companies
Frequently Asked Questions
- What is Guardant Health's common stock, capital shares reserved for future issuance?
- Guardant Health (GH) reported common stock, capital shares reserved for future issuance of $32.08M in Q1 2026.
- How has Guardant Health's common stock, capital shares reserved for future issuance changed year-over-year?
- Guardant Health's common stock, capital shares reserved for future issuance increased by 2.4% year-over-year, from $31.31M to $32.08M.
- What is the long-term trend for Guardant Health's common stock, capital shares reserved for future issuance?
- Over 5 years (2020 to 2025), Guardant Health's common stock, capital shares reserved for future issuance has grown at a 19.9% compound annual growth rate (CAGR), from $11.34M to $28.16M.